Kellan Passow

Kellan Passow has a diverse work experience in the field of scientific research. In 2012, while at St. Olaf College, they collaborated on the development and application of Jmol, an open-source molecular visualization software, for Proteopedia.org. In 2013, at Mayo Clinic, they worked as an Undergraduate Research Fellow, focusing on the effects of microRNAs on metastatic phenotypes in colon cancer cell lines. From 2014 to 2021, they worked at the University of Minnesota, starting as a Research Assistant, where their work focused on the use of unnatural nucleosides and nucleotides as biological and chemical tools. They later transitioned to the role of Postdoctoral Associate. Starting in 2022, Kellan Passow joined Aligos Therapeutics as a Scientist.

Kellan Passow began their education journey in 2010 at St. Olaf College, where they pursued a Bachelor of Arts degree and graduated magna cum laude in 2014. During their time at St. Olaf College, Passow focused on studying Chemistry and Mathematics.

Following the completion of their undergraduate studies, Passow enrolled at the University of Minnesota in 2014. Over the next six years, they pursued a Doctor of Philosophy (Ph.D.) degree in Medicinal Chemistry. The Ph.D. program provided them with an opportunity to deepen their knowledge and expertise in this field.

In summary, Kellan Passow attended St. Olaf College from 2010 to 2014, earning a Bachelor of Arts degree. They later enrolled at the University of Minnesota, where they completed their Doctor of Philosophy in Medicinal Chemistry from 2014 to 2020.